Certified companies profile

Novo Nordisk is a global healthcare company headquartered in Denmark, renowned for its leadership in diabetes care and other chronic diseases. Founded in 1923, the company has grown to become a leading provider of innovative medicines and treatments in areas such as diabetes, obesity, hemophilia, growth disorders, and endocrine diseases. Novo Nordisk’s primary focus is to drive change to defeat diabetes and other serious chronic conditions by developing life-changing therapies and advancing scientific research. The company is deeply committed to improving the lives of people living with chronic conditions through continuous innovation, a patient-centered approach, and a commitment to sustainable healthcare solutions.